The migration of hematopoietic progenitors from the fetal liver to the fetal bone marrow: Lessons learned and possible clinical applications

Experimental Hematology

Volumn 41, Issue 5, 2013, Pages 411-423

  Ciriza, Jesús ^a   Thompson, Heather ^a   Petrosian, Raffi ^a   Manilay, Jennifer O ^a   García Ojeda, Marcos E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE;

AORTA; BONE MARROW; CELL MATURATION; CELL MIGRATION; CHEMOTAXIS; EMBRYO; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; FETUS; FETUS LIVER; GONAD; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; MESONEPHROS; NONHUMAN; ONTOGENY; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION; YOLK SAC;

BONE MARROW; CELL ADHESION MOLECULES; CELL MOVEMENT; CYTOKINES; EMBRYONIC STEM CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LIVER; MODELS, BIOLOGICAL;

EID: 84876859901     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2013.01.009     Document Type: Review

References (132)

1. Nishikawa M., Tahara T., Hinohara A., Miyajima A., Nakahata T., Shimosaka A. Role of the microenvironment of the embryonic aorta-gonad-mesonephros region in hematopoiesis. Ann N Y Acad Sci 2001, 938:109-116.
2. Mikkola H.K., Orkin S.H. The journey of developing hematopoietic stem cells. Development 2006, 133:3733-3744.
3. Godin I., Cumano A. Of birds and mice: Hematopoietic stem cell development. Int J Dev Biol 2005, 49:251-257.
4. McKinney-Freeman S.L., Naveiras O., Yates F., et al. Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells. Blood 2009, 114:268-278.
5. Alvarez-Silva M., Belo-Diabangouaya P., Salaun J., Dieterlen-Lievre F. Mouse placenta is a major hematopoietic organ. Development 2003, 130:5437-5444.
6. Moore M.A., Metcalf D. Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol 1970, 18:279-296.
7. Tyan M.L., Herzenberg L.A. Studies on the ontogeny of the mouse immune system. II. Immunoglobulin-producing cells. J Immunol 1968, 101:446-450.
8. Koushik S.V., Wang J., Rogers R., et al. Targeted inactivation of the sodium-calcium exchanger (Ncx1) results in the lack of a heartbeat and abnormal myofibrillar organization. FASEB J 2001, 15:1209-1211.
9. Lux C.T., Yoshimoto M., McGrath K., Conway S.J., Palis J., Yoder M.C. All primitive and definitive hematopoietic progenitor cells emerging before E10 in the mouse embryo are products of the yolk sac. Blood 2008, 111:3435-3438.
10. Ghiaur G., Ferkowicz M.J., Milsom M.D., et al. Rac1 is essential for intraembryonic hematopoiesis and for the initial seeding of fetal liver with definitive hematopoietic progenitor cells. Blood 2008, 111:3313-3321.
11. North T., Gu T.L., Stacy T., et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 1999, 126:2563-2575.
12. Samokhvalov I.M., Samokhvalova N.I., Nishikawa S. Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature 2007, 446:1056-1061.
13. Cumano A., Ferraz J.C., Klaine M., Di Santo J.P., Godin I. Intraembryonic, but not yolk sac hematopoietic precursors, isolated before circulation, provide long-term multilineage reconstitution. Immunity 2001, 15:477-485.
14. Matsuoka S., Tsuji K., Hisakawa H., et al. Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region-derived stromal cells. Blood 2001, 98:6-12.
15. Yoder M.C., Hiatt K., Dutt P., Mukherjee P., Bodine D.M., Orlic D. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity 1997, 7:335-344.
16. Yoder M.C., Hiatt K., Mukherjee P. In vivo repopulating hematopoietic stem cells are present in the murine yolk sac at day 9.0 postcoitus. Proc Nat Acad Sci U S A 1997, 94:6776-6780.
17. Yoder M.C., Hiatt K. Engraftment of embryonic hematopoietic cells in conditioned newborn recipients. Blood 1997, 89:2176-2183.
18. Orkin S.H., Zon L.I. Hematopoiesis: An evolving paradigm for stem cell biology. Cell 2008, 132:631-644.
19. Zovein A.C., Hofmann J.J., Lynch M., et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 2008, 3:625-636.
20. Boisset J.C., van Cappellen W., Andrieu-Soler C., Galjart N., Dzierzak E., Robin C. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 2010, 464:116-120.
21. Cumano A., Dieterlen-Lievre F., Godin I. Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. Cell 1996, 86:907-916.
22. Muller A.M., Medvinsky A., Strouboulis J., Grosveld F., Dzierzak E. Development of hematopoietic stem cell activity in the mouse embryo. Immunity 1994, 1:291-301.
23. Medvinsky A., Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996, 86:897-906.
24. Kumano K., Chiba S., Kunisato A., et al. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 2003, 18:699-711.
25. Matsubara A., Iwama A., Yamazaki S., et al. Endomucin, a CD34-like sialomucin, marks hematopoietic stem cells throughout development. J Exp Med 2005, 202:1483-1492.
26. Owen R.D. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945, 102:400-401.
27. Till J.E., McCulloch E.A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961, 14:212-222.
28. Zeigler B.M., Sugiyama D., Chen M., Guo Y., Downs K.M., Speck N.A. The allantois and chorion, when isolated before circulation or chorio-allantoic fusion, have hematopoietic potential. Development 2006, 133:4183-4192.
29. Gekas C., Dieterlen-Lievre F., Orkin S.H., Mikkola H.K. The placenta is a niche for hematopoietic stem cells. Dev Cell 2005, 8:365-375.
30. Ottersbach K., Dzierzak E. The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev Cell 2005, 8:377-387.
31. Kumaravelu P., Hook L., Morrison A.M., et al. Quantitative developmental anatomy of definitive haematopoietic stem cells/long-term repopulating units (HSC/RUs): Role of the aorta-gonad-mesonephros (AGM) region and the yolk sac in colonisation of the mouse embryonic liver. Development 2002, 129:4891-4899.
32. Morrison S.J., Hemmati H.D., Wandycz A.M., Weissman I.L. The purification and characterization of fetal liver hematopoietic stem cells. Proc Nat Acad Sci U S A 1995, 92:10302-10306.
33. Houssaint E. Differentiation of the mouse hepatic primordium. II. Extrinsic origin of the haemopoietic cell line. Cell Differ 1981, 10:243-252.
34. Morrison S.J., Uchida N., Weissman I.L. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol 1995, 11:35-71.
35. Johnson G.R., Moore M.A. Role of stem cell migration in initiation of mouse foetal liver haemopoiesis. Nature 1975, 258:726-728.
36. Ema H., Nakauchi H. Expansion of hematopoietic stem cells in the developing liver of a mouse embryo. Blood 2000, 95:2284-2288.
37. Ikuta K., Weissman I.L. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Nat Acad Sci U S A 1992, 89:1502-1506.
38. Christensen J.L., Wright D.E., Wagers A.J., Weissman I.L. Circulation and chemotaxis of fetal hematopoietic stem cells. PLoS Biol 2004, 2:E75.
39. Kim I., He S., Yilmaz O.H., Kiel M.J., Morrison S.J. Enhanced purification of fetal liver hematopoietic stem cells using SLAM family receptors. Blood 2006, 108:737-744.
40. Delassus S., Cumano A. Circulation of hematopoietic progenitors in the mouse embryo. Immunity 1996, 4:97-106.
41. Godin I., García-Porrero J.A., Dieterlen-Lievre F., Cumano A. Stem cell emergence and hemopoietic activity are incompatible in mouse intraembryonic sites. J Exp Med 1999, 190:43-52.
42. Cumano A., Godin I. Ontogeny of the hematopoietic system. Annu Rev Immunol 2007, 25:745-785.
43. Wolber F.M., Leonard E., Michael S., Orschell-Traycoff C.M., Yoder M.C., Srour E.F. Roles of spleen and liver in development of the murine hematopoietic system. Exp Hematol 2002, 30:1010-1019.
44. Zanjani E.D., Ascensao J.L., Tavassoli M. Liver-derived fetal hematopoietic stem cells selectively and preferentially home to the fetal bone marrow. Blood 1993, 81:399-404.
45. Aguila H.L., Rowe D.W. Skeletal development, bone remodeling, and hematopoiesis. Immunol Rev 2005, 208:7-18.
46. Deguchi K., Yagi H., Inada M., Yoshizaki K., Kishimoto T., Komori T. Excessive extramedullary hematopoiesis in Cbfa1-deficient mice with a congenital lack of bone marrow. Biochem Biophys Res Commun 1999, 255:352-359.
47. Jacenko O., Roberts D.W., Campbell M.R., McManus P.M., Gress C.J., Tao Z. Linking hematopoiesis to endochondral skeletogenesis through analysis of mice transgenic for collagen X. Am J Pathol 2002, 160:2019-2034.
48. Jacenko O., Chan D., Franklin A., et al. A dominant interference collagen X mutation disrupts hypertrophic chondrocyte pericellular matrix and glycosaminoglycan and proteoglycan distribution in transgenic mice. Am J Pathol 2001, 159:2257-2269.
49. Gress C.J., Jacenko O. Growth plate compressions and altered hematopoiesis in collagen X null mice. Journal Cell Biol 2000, 149:983-993.
50. Carlevaro M.F., Cermelli S., Cancedda R., Descalzi Cancedda F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: Auto-paracrine role during endochondral bone formation. J Cell Sci 2000, 113(Pt 1):59-69.
51. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5:623-628.
52. Gerber H.P., Malik A.K., Solar G.P., et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 2002, 417:954-958.
53. Chan C.K., Chen C.C., Luppen C.A., et al. Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 2009, 457:490-494.
54. Mendez-Ferrer S., Lucas D., Battista M., Frenette P.S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452:442-447.
55. Wright D.E., Bowman E.P., Wagers A.J., Butcher E.C., Weissman I.L. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 2002, 195:1145-1154.
56. Nagasawa T., Hirota S., Tachibana K., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
57. Ma Q., Jones D., Borghesani P.R., et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Nat Acad Sci U S A 1998, 95:9448-9453.
58. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.
59. Mazo I.B., Quackenbush E.J., Lowe J.B., von Andrian U.H. Total body irradiation causes profound changes in endothelial traffic molecules for hematopoietic progenitor cell recruitment to bone marrow. Blood 2002, 99:4182-4191.
60. Kawabata K., Ujikawa M., Egawa T., et al. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc Nat Acad Sci U S A 1999, 96:5663-5667.
61. Ara T., Tokoyoda K., Sugiyama T., Egawa T., Kawabata K., Nagasawa T. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity 2003, 19:257-267.
62. Ciriza J., García-Ojeda M.E. Expression of migration-related genes is progressively upregulated in murine Lineage-Sca-1+c-Kit+ population from the fetal to adult stages of development. Stem Cell Res Ther 2010, 1:14.
63. Humbles A.A., Lu B., Friend D.S., et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Nat Acad Sci U S A 2002, 99:1479-1484.
64. Wendland M., Czeloth N., Mach N., et al. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc Nat Acad Sci U S A 2007, 104:6347-6352.
65. Okumura N., Tsuji K., Ebihara Y., et al. Chemotactic and chemokinetic activities of stem cell factor on murine hematopoietic progenitor cells. Blood 1996, 87:4100-4108.
66. Smith-Berdan S., Nguyen A., Hassanein D., et al. Robo4 cooperates with CXCR4 to specify hematopoietic stem cell localization to bone marrow niches. Cell Stem Cell 2010, 8:72-83.
67. Adams G.B., Chabner K.T., Alley I.R., et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 2006, 439:599-603.
68. Lam B.S., Cunningham C., Adams G.B. Pharmacologic modulation of the calcium-sensing receptor enhances hematopoietic stem cell lodgment in the adult bone marrow. Blood 2011, 117:1167-1175.
69. Ciriza J., Hall D., Lu A., De Sena J.R., Al-Kuhlani M., García-Ojeda M.E. Single-cell analysis of murine long-term hematopoietic stem cells reveals distinct patterns of gene expression during fetal migration. PLoS One 2012, 7:e30542.
70. Corada M., Mariotti M., Thurston G., et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Nat Acad Sci U S A 1999, 96:9815-9820.
71. Kim I., Yilmaz O.H., Morrison S.J. CD144 (VE-cadherin) is transiently expressed by fetal liver hematopoietic stem cells. Blood 2005, 106:903-905.
72. Taoudi S., Gonneau C., Moore K., et al. Extensive hematopoietic stem cell generation in the AGM region via maturation of VE-cadherin+CD45+ pre-definitive HSCs. Cell Stem Cell 2008, 3:99-108.
73. Taoudi S., Morrison A.M., Inoue H., Gribi R., Ure J., Medvinsky A. Progressive divergence of definitive haematopoietic stem cells from the endothelial compartment does not depend on contact with the foetal liver. Development 2005, 132:4179-4191.
74. Fraser S.T., Ogawa M., Yu R.T., Nishikawa S., Yoder M.C., Nishikawa S. Definitive hematopoietic commitment within the embryonic vascular endothelial-cadherin(+) population. Exp Hematol 2002, 30:1070-1078.
75. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841.
76. Lai C.F., Cheng S.L., Mbalaviele G., et al. Accentuated ovariectomy-induced bone loss and altered osteogenesis in heterozygous N-cadherin null mice. J Bone Miner Res 2006, 21:1897-1906.
77. Hosokawa K., Arai F., Yoshihara H., et al. Knockdown of N-cadherin suppresses the long-term engraftment of hematopoietic stem cells. Blood 2010, 116:554-563.
78. Kiel M.J., Radice G.L., Morrison S.J. Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem Cell 2007, 1:204-217.
79. Kiel M.J., Acar M., Radice G.L., Morrison S.J. Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance. Cell Stem Cell 2009, 4:170-179.
80. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25.
81. Hynes R.O. Integrins: Bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
82. Potocnik A.J., Brakebusch C., Fassler R. Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow. Immunity 2000, 12:653-663.
83. Katayama Y., Hidalgo A., Peired A., Frenette P.S. Integrin alpha4beta7 and its counterreceptor MAdCAM-1 contribute to hematopoietic progenitor recruitment into bone marrow following transplantation. Blood 2004, 104:2020-2026.
84. Papayannopoulou T., Craddock C., Nakamoto B., Priestley G.V., Wolf N.S. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Nat Acad Sci U S A 1995, 92:9647-9651.
85. Vermeulen M., Le Pesteur F., Gagnerault M.C., Mary J.Y., Sainteny F., Lepault F. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 1998, 92:894-900.
86. Zanjani E.D., Flake A.W., Almeida-Porada G., Tran N., Papayannopoulou T. Homing of human cells in the fetal sheep model: Modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function. Blood 1999, 94:2515-2522.
87. Arroyo A.G., Taverna D., Whittaker C.A., et al. In vivo roles of integrins during leukocyte development and traffic: insights from the analysis of mice chimeric for alpha 5, alpha v, and alpha 4 integrins. J Immunol 2000, 165:4667-4675.
88. Ruegg C., Postigo A.A., Sikorski E.E., Butcher E.C., Pytela R., Erle D.J. Role of integrin alpha 4 beta 7/alpha 4 beta P in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering. J Cell Biol 1992, 117:179-189.
89. Scott L.M., Priestley G.V., Papayannopoulou T. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol 2003, 23:9349-9360.
90. Craddock C.F., Nakamoto B., Andrews R.G., Priestley G.V., Papayannopoulou T. Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice. Blood 1997, 90:4779-4788.
91. van der Loo J.C., Xiao X., McMillin D., Hashino K., Kato I., Williams D.A. VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. J Clin Invest 1998, 102:1051-1061.
92. Peled A., Kollet O., Ponomaryov T., et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 2000, 95:3289-3296.
93. Papayannopoulou T., Priestley G.V., Nakamoto B., Zafiropoulos V., Scott L.M., Harlan J.M. Synergistic mobilization of hemopoietic progenitor cells using concurrent beta1 and beta2 integrin blockade or beta2-deficient mice. Blood 2001, 97:1282-1288.
94. Mohle R., Murea S., Kirsch M., Haas R. Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery. Exp Hematol 1995, 23:1535-1542.
95. Mendez-Ferrer S., Frenette P.S. Hematopoietic stem cell trafficking: Regulated adhesion and attraction to bone marrow microenvironment. Ann N Y Acad Sci 2007, 1116:392-413.
96. Mazo I.B., Gutierrez-Ramos J.C., Frenette P.S., Hynes R.O., Wagner D.D., von Andrian U.H. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med 1998, 188:465-474.
97. Frenette P.S., Subbarao S., Mazo I.B., von Andrian U.H., Wagner D.D. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Nat Acad Sci U S A 1998, 95:14423-14428.
98. Papayannopoulou T., Priestley G.V., Nakamoto B., Zafiropoulos V., Scott L.M. Molecular pathways in bone marrow homing: dominant role of alpha(4)beta(1) over beta(2)-integrins and selectins. Blood 2001, 98:2403-2411.
99. Kopp H.G., Avecilla S.T., Hooper A.T., Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology 2005, 20:349-356.
100. Hidalgo A., Weiss L.A., Frenette P.S. Functional selectin ligands mediating human CD34(+) cell interactions with bone marrow endothelium are enhanced postnatally. J Clin Invest 2002, 110:559-569.
101. Katayama Y., Hidalgo A., Furie B.C., Vestweber D., Furie B., Frenette P.S. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood 2003, 102:2060-2067.
102. Sato H., Takino T., Okada Y., et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994, 370:61-65.
103. Bourboulia D., Stetler-Stevenson W.G. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Seminars in cancer biology 2010, 20:161-168.
104. Zitka O., Kukacka J., Krizkova S., et al. Matrix metalloproteinases. Curr Med Chem 2010, 17:3751-3768.
105. Sato H., Okada Y., Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thromb Haemost 1997, 78:497-500.
106. Forsberg E.C., Prohaska S.S., Katzman S., Heffner G.C., Stuart J.M., Weissman I.L. Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet 2005, 1:e28.
107. Morgunova E., Tuuttila A., Bergmann U., Tryggvason K. Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc Nat Acad Sci U S A 2002, 99:7414-7419.
108. Murphy G., Knauper V. Relating matrix metalloproteinase structure to function: Why the " hemopexin" domain?. Matrix Biol 1997, 15:511-518.
109. Janowska-Wieczorek A., Marquez L.A., Nabholtz J.M., et al. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane. Blood 1999, 93:3379-3390.
110. Hashimoto K., Noshiro M., Ohno S., et al. Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen. Biochimica Biophys Acta 1997, 1355:303-314.
111. Lemoli R.M., Ferrari D., Fogli M., et al. Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo. Blood 2004, 104:1662-1670.
112. Shirvaikar N., Reca R., Jalili A., et al. CFU-megakaryocytic progenitors expanded ex vivo from cord blood maintain their in vitro homing potential and express matrix metalloproteinases. Cytotherapy 2008, 10:182-192.
113. Janowska-Wieczorek A., Marquez L.A., Dobrowsky A., Ratajczak M.Z., Cabuhat M.L. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol 2000, 28:1274-1285.
114. Kodali R., Hajjou M., Berman A.B., et al. Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells. Cardiovasc Res 2006, 69:706-715.
115. Libura J., Drukala J., Majka M., et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 2002, 100:2597-2606.
116. Chinni S.R., Sivalogan S., Dong Z., et al. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate 2006, 66:32-48.
117. McQuibban G.A., Butler G.S., Gong J.H., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 2001, 276:43503-43508.
118. Bradley J.A., Bolton E.M., Pedersen R.A. Stem cell medicine encounters the immune system. Nat Rev 2002, 2:859-871.
119. Nakano T., Kodama H., Honjo T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 1994, 265:1098-1101.
120. Thompson H.L., Manilay J.O. Embryonic stem cell-derived hematopoietic stem cells: challenges in development, differentiation, and immunogenicity. Curr Top Med Chem 2011, 11:1621-1637.
121. Guo Y., Hangoc G., Bian H., Pelus L.M., Broxmeyer H.E. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells 2005, 23:1324-1332.
122. de Pooter R.F., Cho S.K., Zuniga-Pflucker J.C. In vitro generation of lymphocytes from embryonic stem cells. Methods Mol Biol 2005, 290:135-147.
123. Mikkola H.K., Fujiwara Y., Schlaeger T.M., Traver D., Orkin S.H. Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood 2003, 101:508-516.
124. Ferkowicz M.J., Starr M., Xie X., et al. CD41 expression defines the onset of primitive and definitive hematopoiesis in the murine embryo. Development 2003, 130:4393-4403.
125. Yamane T., Hosen N., Yamazaki H., Weissman I.L. Expression of AA4.1 marks lymphohematopoietic progenitors in early mouse development. Proc Nat Acad Sci U S A 2009, 106:8953-8958.
126. Kinashi T., Springer T.A. Steel factor and c-kit regulate cell-matrix adhesion. Blood 1994, 83:1033-1038.
127. Levesque J.P., Leavesley D.I., Niutta S., Vadas M., Simmons P.J. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 1995, 181:1805-1815.
128. Burt R.K., Verda L., Kim D.A., Oyama Y., Luo K., Link C. Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease. J Exp Med 2004, 199:895-904.
129. Melichar H., Li O., Ross J., et al. Comparative study of hematopoietic differentiation between human embryonic stem cell lines. PLoS One 2011, 6:e19854.
130. Colmone A., Amorim M., Pontier A.L., Wang S., Jablonski E., Sipkins D.A. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 2008, 322:1861-1865.
131. Ara T., Itoi M., Kawabata K., et al. A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo. J Immunol 2003, 170:4649-4655.
132. Heissig B., Hattori K., Dias S., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637.